TABLE - UroMed Corp (NASDAQ:URMD) Q1 loss narrows
Reuters, Friday, April 17, 1998 at 11:13
NEEDHAM, Mass., April 17 (Reuters) -
(In thousands, except share data)
Three Months Ended
March 31,
1998 1997
Revenues $ 61 $ 263
Costs and expenses:
Cost of revenues 1,135 1,001
Research and development 1,921 2,308
Marketing and sales 1,764 4,136
General and administrative 1,077 1,317
Restructuring 1,024 ---
Total costs and expenses 6,921 8,762
Loss from operations (6,860) (8,499)
Interest income 897 1,302
Interest expense (1,134) (1,134)
Net loss (7,097) (8,331)
Basic and diluted
net loss per share (.27) (.31)
Weighted average
common shares
outstanding 26,773,712 26,488,618 |
